See more : FocalTech Systems Co., Ltd. (3545.TW) Income Statement Analysis – Financial Results
Complete financial analysis of China Traditional Chinese Medicine Holdings Co. Limited (CHIZF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of China Traditional Chinese Medicine Holdings Co. Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- SIGNA Sports United N.V. (SSUNF) Income Statement Analysis – Financial Results
- Samesystem A/S (SAME.CO) Income Statement Analysis – Financial Results
- Toromont Industries Ltd. (TMTNF) Income Statement Analysis – Financial Results
- Wing Tai Holdings Limited (W05.SI) Income Statement Analysis – Financial Results
- Fusion Fuel Green PLC (HTOOW) Income Statement Analysis – Financial Results
China Traditional Chinese Medicine Holdings Co. Limited (CHIZF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.china-tcm.com.cn
About China Traditional Chinese Medicine Holdings Co. Limited
China Traditional Chinese Medicine Holdings Co. Limited, an investment holding company, engages in the research and development, production, and sale of Chinese medicine and pharmaceutical products in the People's Republic of China. The company offers granules, finished drugs, decoction pieces, and healthcare products. It is also involved in the plantation and management of Chinese medicinal herbs; manufacturing of traditional Chinese medicines (TCM); trading of pharmaceutical products; provision of TCM marketing, advertising, and consulting services; and retail of pharmaceuticals and decoction products. The company also provides property leasing services. It sells its products to hospitals and retail pharmacies. The company was formerly known as China Traditional Chinese Medicine Co. Limited and changed its name to China Traditional Chinese Medicine Holdings Co. Limited in July 2016. China Traditional China Traditional Chinese Medicine Holdings Co. Limited was founded in 1573 and is headquartered in Wan Chai, Hong Kong.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 18.12B | 14.30B | 19.05B | 14.81B | 14.32B | 11.26B | 8.34B | 6.53B | 3.71B | 2.69B | 1.39B | 1.02B | 822.22M | 800.39M | 590.06M | 390.53M | 333.39M | 109.92M | 857.77M | 789.17M | 763.94M | 777.28M | 837.68M | 851.49M | 843.28M |
| Cost of Revenue | 8.85B | 7.11B | 7.22B | 5.68B | 5.75B | 5.07B | 3.69B | 2.75B | 1.52B | 1.04B | 568.83M | 462.92M | 378.38M | 353.91M | 305.94M | 251.16M | 216.76M | 67.34M | 964.02M | 796.65M | 681.68M | 575.48M | 696.41M | 753.56M | 567.82M |
| Gross Profit | 9.27B | 7.20B | 11.83B | 9.13B | 8.58B | 6.19B | 4.65B | 3.79B | 2.19B | 1.65B | 825.78M | 558.18M | 443.84M | 446.48M | 284.12M | 139.37M | 116.63M | 42.58M | -106.25M | -7.49M | 82.25M | 201.80M | 141.27M | 97.93M | 275.46M |
| Gross Profit Ratio | 51.18% | 50.32% | 62.09% | 61.64% | 59.88% | 55.01% | 55.79% | 57.98% | 59.15% | 61.50% | 59.21% | 54.66% | 53.98% | 55.78% | 48.15% | 35.69% | 34.98% | 38.74% | -12.39% | -0.95% | 10.77% | 25.96% | 16.86% | 11.50% | 32.67% |
| Research & Development | 685.63M | 611.83M | 694.44M | 550.47M | 464.00M | 346.54M | 202.16M | 186.83M | 112.32M | 67.88M | 45.95M | 34.51M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.04B | 944.40M | 974.45M | 707.28M | 686.19M | 552.29M | 349.45M | 329.99M | 269.99M | 217.02M | 167.75M | 113.52M | 105.66M | 93.80M | 69.09M | 37.20M | 35.25M | 20.94M | 25.46M | 23.99M | 24.00M | 30.70M | 19.42M | 13.18M | 21.79M |
| Selling & Marketing | 6.40B | 4.60B | 7.58B | 5.59B | 5.11B | 3.42B | 2.44B | 1.97B | 1.20B | 903.49M | 404.63M | 233.23M | 265.98M | 270.29M | 142.30M | 58.32M | 52.45M | 23.28M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 7.45B | 5.55B | 8.56B | 5.59B | 5.11B | 3.42B | 2.79B | 2.30B | 1.20B | 903.49M | 404.63M | 233.23M | 371.64M | 364.09M | 211.39M | 95.52M | 87.70M | 44.21M | 25.46M | 23.99M | 24.00M | 30.70M | 19.42M | 13.18M | 21.79M |
| Other Expenses | -284.94M | -152.25M | -127.97M | 510.21M | 564.86M | 36.19M | -5.73M | -4.10M | -3.83M | 244.00K | -1.36M | 557.19K | -10.47M | -19.07M | -11.61M | -4.39M | 0.00 | 0.00 | 727.26M | 18.62M | 37.84M | 29.46M | 30.39M | 33.52M | 33.66M |
| Operating Expenses | 7.85B | 6.01B | 9.12B | 6.65B | 6.14B | 4.22B | 2.93B | 2.42B | 1.55B | 1.11B | 569.55M | 345.88M | 361.17M | 345.02M | 199.78M | 91.13M | 87.70M | 44.21M | 752.72M | 42.62M | 61.85M | 60.16M | 49.81M | 46.70M | 55.46M |
| Cost & Expenses | 16.69B | 13.11B | 16.35B | 12.33B | 11.88B | 9.29B | 6.61B | 5.16B | 3.06B | 2.14B | 1.14B | 808.80M | 739.56M | 698.92M | 505.72M | 342.30M | 304.46M | 111.55M | 1.72B | 839.27M | 743.53M | 635.64M | 746.22M | 800.26M | 623.28M |
| Interest Income | 65.26M | 67.27M | 62.58M | 47.60M | 51.25M | 43.25M | 32.56M | 14.59M | 96.30M | 1.69M | 7.75M | 20.06M | 1.18M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 199.05M | 220.70M | 222.03M | 244.67M | 301.05M | 292.30M | 221.07M | 73.42M | 70.18M | 64.22M | 35.18M | 19.19M | 7.55M | 24.70M | 25.97M | 25.99M | 0.00 | 430.72M | 181.12K | 17.34M | 33.40M | 59.81M | 63.00M | 77.55M | 119.90M |
| Depreciation & Amortization | 1.13B | 1.10B | 849.60M | 684.08M | 590.83M | 529.17M | 423.39M | 336.76M | 168.40M | 119.10M | 68.28M | 37.60M | 46.22M | 46.20M | 45.94M | 31.01M | 30.92M | 90.24M | 97.80M | 101.41M | 100.06M | 95.01M | 0.00 | -7.98M | -14.61M |
| EBITDA | 2.56B | 2.16B | 3.59B | 3.16B | 3.05B | 2.66B | 2.19B | 1.71B | 921.02M | 670.79M | 341.04M | 271.52M | 128.89M | 147.67M | 130.27M | 79.25M | 62.92M | 88.61M | -761.16M | 51.30M | 120.47M | 236.65M | 91.46M | 51.23M | 220.00M |
| EBITDA Ratio | 14.11% | 16.17% | 18.88% | 21.69% | 21.24% | 22.95% | 26.31% | 27.12% | 24.61% | 24.74% | 23.83% | 26.57% | 15.68% | 18.45% | 22.08% | 20.29% | 17.95% | 80.61% | -88.74% | 6.50% | 15.77% | 30.45% | 10.92% | 6.02% | 26.09% |
| Operating Income | 1.43B | 1.06B | 2.75B | 2.49B | 2.46B | 2.16B | 1.79B | 1.44B | 755.75M | 545.39M | 272.76M | 233.36M | 82.67M | 101.47M | 84.33M | 48.24M | 32.00M | 478.29K | -839.83M | -50.11M | 20.41M | 141.64M | 91.46M | 59.21M | 234.61M |
| Operating Income Ratio | 7.88% | 7.44% | 14.45% | 16.82% | 17.18% | 19.15% | 21.43% | 21.97% | 20.37% | 20.27% | 19.56% | 22.85% | 10.05% | 12.68% | 14.29% | 12.35% | 9.60% | 0.44% | -97.91% | -6.35% | 2.67% | 18.22% | 10.92% | 6.95% | 27.82% |
| Total Other Income/Expenses | -202.74M | -224.17M | -232.78M | -260.54M | -306.10M | -299.33M | -219.22M | -131.44M | 149.25M | -62.58M | -35.18M | 1.33M | -6.22M | -3.26M | -4.68M | -1.21M | -1.18M | -6.38M | -19.31M | -22.26M | -28.19M | -36.76M | -49.96M | -73.06M | -83.94M |
| Income Before Tax | 1.22B | 840.11M | 2.52B | 2.23B | 2.15B | 1.86B | 1.57B | 1.30B | 769.37M | 481.17M | 237.58M | 214.17M | 76.45M | 98.20M | 79.65M | 47.02M | 30.83M | -5.90M | -859.14M | -72.37M | -7.78M | 104.88M | 41.50M | -13.85M | 150.68M |
| Income Before Tax Ratio | 6.76% | 5.87% | 13.23% | 15.06% | 15.05% | 16.49% | 18.80% | 19.96% | 20.74% | 17.89% | 17.04% | 20.97% | 9.30% | 12.27% | 13.50% | 12.04% | 9.25% | -5.36% | -100.16% | -9.17% | -1.02% | 13.49% | 4.95% | -1.63% | 17.87% |
| Income Tax Expense | -171.54M | 119.36M | 396.86M | 369.45M | 381.32M | 289.67M | 255.80M | 217.26M | 118.33M | 69.63M | 38.22M | 42.94M | 16.79M | 24.84M | 19.58M | 4.35M | 7.37M | 511.38K | -18.94M | -7.94M | 5.74M | 29.21M | 14.80M | 2.41M | 12.71M |
| Net Income | 1.29B | 764.49M | 1.93B | 1.66B | 1.59B | 1.44B | 1.17B | 966.93M | 621.69M | 413.09M | 198.46M | 166.78M | 58.33M | 51.92M | 38.79M | 17.90M | 23.45M | -432.86M | -840.21M | -59.51M | -18.73M | 52.62M | 13.66M | -20.75M | 102.01M |
| Net Income Ratio | 7.09% | 5.34% | 10.14% | 11.23% | 11.09% | 12.78% | 14.04% | 14.80% | 16.76% | 15.36% | 14.23% | 16.33% | 7.09% | 6.49% | 6.57% | 4.58% | 7.03% | -393.78% | -97.95% | -7.54% | -2.45% | 6.77% | 1.63% | -2.44% | 12.10% |
| EPS | 0.26 | 0.15 | 0.38 | 0.33 | 0.32 | 0.30 | 0.26 | 0.22 | 0.17 | 0.16 | 0.10 | 0.09 | 0.03 | 0.03 | 0.02 | 0.02 | 0.01 | -0.52 | -1.01 | -0.07 | -0.02 | 0.06 | 0.02 | -0.03 | 0.12 |
| EPS Diluted | 0.26 | 0.15 | 0.38 | 0.33 | 0.32 | 0.30 | 0.26 | 0.22 | 0.17 | 0.16 | 0.10 | 0.09 | 0.03 | 0.03 | 0.02 | 0.02 | 0.01 | -0.52 | -1.01 | -0.07 | -0.02 | 0.06 | 0.02 | -0.03 | 0.12 |
| Weighted Avg Shares Out | 5.04B | 5.04B | 5.04B | 5.04B | 5.04B | 4.82B | 4.43B | 4.45B | 3.69B | 2.53B | 2.05B | 1.78B | 1.78B | 1.73B | 1.56B | 830.97M | 830.53M | 830.22M | 830.15M | 829.97M | 828.82M | 829.15M | 830.65M | 827.64M | 826.03M |
| Weighted Avg Shares Out (Dil) | 5.04B | 5.04B | 5.04B | 5.04B | 5.04B | 4.82B | 4.43B | 4.45B | 3.69B | 2.53B | 2.05B | 1.78B | 1.78B | 1.73B | 1.56B | 830.97M | 830.53M | 830.22M | 830.15M | 829.97M | 828.82M | 829.15M | 830.65M | 827.64M | 826.03M |
Source: https://incomestatements.info
Category: Stock Reports